Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | MPO | P05164 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | BLM | P54132 | 1/20 | 0.53 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.53 |
| ▸ | CTSC | P53634 | 4/20 | 0.49 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.48 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.48 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.48 |
| ▸ | SOS1 | Q07889 | 2/20 | 0.47 |
| ▸ | NLN | Q9BYT8 | 1/20 | 0.47 |
| ▸ | KRAS | P01116 | 1/20 | 0.47 |
| ▸ | CTSL | P07711 | 2/20 | 0.45 |
| ▸ | RUVBL1 | Q9Y265 | 1/20 | 0.45 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1272199 | 0.91 | CTSC (0.53) | KDM4EMEN1LMNAMPOMAPT | |
| SCHEMBL30834724 | 0.85 | OPRM1 (0.56) | KDM4EMEN1LMNAMPOMAPT | |
| SCHEMBL26605070 | 0.85 | KDM4E (0.60) | KDM4EMEN1LMNAMPOMAPT | |
| SCHEMBL26605065 | 0.85 | KDM4E (0.60) | KDM4EMEN1LMNAMPOMAPT | |
| SCHEMBL16317501 | 0.85 | KDM4E (0.65) | KDM4EMEN1LMNAMPOMAPT | |
| SCHEMBL29378473 | 0.85 | KDM4E (0.65) | KDM4EMEN1LMNAMPOMAPT | |
| SCHEMBL18541537 | 0.85 | KDM4E (0.65) | KDM4EMEN1LMNAMPOMAPT | |
| SCHEMBL1271007 | 0.83 | CTSL (0.62) | MAPTCTSLBCHEACHE | |
| SCHEMBL1270414 | 0.81 | CTSC (0.51) | KDM4EMEN1LMNAMPOMAPT | |
| SCHEMBL7593998 | 0.81 | KDM4E (0.63) | KDM4EMEN1LMNAMPOMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110038885-A1 | CHEMOKINE ANALOGS | IPSEN PHARMA S.A.S. (FR) | 2011-02-17 | — | — | US | claimed |
| US-20110038885-A1 | CHEMOKINE ANALOGS | IPSEN PHARMA S.A.S. (FR) | 2011-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110038885-A1 | CHEMOKINE ANALOGS | CCL11, CCL5, CCL2 | KDM4E 4825/4885MEN1 2251/4885LMNA 4604/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.